Towards a Healthcare Cost Catalogue for Middle EAST and North Africa: A Systematic Review of Costs Reported in Health Economic Publications from Jordan, Lebanon Palestine and Syria 1995-2019

Author(s)

Zrubka Z1, Abu-Zahra T2, Almaaytah A3, Péntek M2, Gulácsi L4
1Óbuda University, Budapest, PE, Hungary, 2Corvinus University of Budapest, Budapest, Hungary, 3Jordan University of Science and Technology, Irbid, Jordan, 4Óbuda University, Budapest, Hungary

Presentation Documents

OBJECTIVES : To review the costs of illness and unit costs published in health economic papers from Jordan, Lebanon Palestine and Syria, as part of a project systematically reviewing health economic research in 17 countries from the Middle East North Africa (MENA) region.

METHODS : PRISMA guidelines were followed. A Pubmed search was conducted up to 15th December 2019. English language full-text articles of original research on humans were included if the local population from Jordan, Lebanon, Palestine or Syria was involved and unit- or composite costs items for 1995-2019 were reported. Eligible studies from previous systematic reviews from MENA were also included. All data were extracted in a multi-stage peer-review process involving two researchers.

RESULTS : From 1646 citations of full-text English articles and 3 systematic reviews, we identified 185 eligible papers reporting costs from MENA. Out of those, 20 (10.8%) reported costs primarily from Jordan (n=12, 60%), followed by Palestine (n=4, 20%) and Syria (n=2, 10%). Two papers (10%) were multi-country studies, including also Lebanon. Altogether 45% of the papers reported health outcomes, and 670 cost items were reported from the four countries. The costing year was 2015-2019 for 37.5% of the cost items. Most costs were reported for coronary heart disease (n=64, 9.6%), followed by colorectal cancer (n=38, 5.7%) and Hepatitis-A infection (n=26, 3.9%). From all cost items 66.0%, 7.6%, 1.0%, and 25.4% were direct healthcare-, direct non-healthcare-, indirect-, and total-costs, respectively. The source was primary research for 89.7% of the costs, secondary local data for 1.6%, secondary foreign data for 0.8%, modelling for 5.2%, and assumption for 2.7%.

CONCLUSIONS : There is a scarcity of healthcare costs data in the four countries and mainly direct healthcare costs were reported. Multi-country studies allowing inter-country comparisons and transferability analyses in the region are encouraged to speed up the availability of input data for health economic research.

Conference/Value in Health Info

2020-11, ISPOR Europe 2020, Milan, Italy

Value in Health, Volume 23, Issue S2 (December 2020)

Code

PNS38

Topic

Economic Evaluation

Disease

No Specific Disease

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×